跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71,040 条关于
“SC Johnson & Son, Inc.”
全部
71,040
临床试验
37,929
药物
2,648
机构
6,387
资讯
24,076
去年
WHO Endorses First New Malaria Vector Control Tool in Four Decades as Spatial Repellents Show 56% Protection Rate
去年
European Commission Approves Darzalex SC with VRd for Newly Diagnosed Multiple Myeloma
去年
J&J Seeks FDA Approval for Subcutaneous TREMFYA® Induction in Ulcerative Colitis
2年前
Johnson & Johnson Seeks FDA Approval for Subcutaneous Amivantamab in NSCLC
去年
Johnson & Johnson Seeks FDA Approval for Subcutaneous TREMFYA® in Ulcerative Colitis
去年
Johnson & Johnson Seeks FDA Approval for Subcutaneous Tremfya in Ulcerative Colitis
去年
Johnson & Johnson Seeks FDA Approval for Subcutaneous Tremfya in Ulcerative Colitis
去年
Johnson & Johnson Seeks FDA Approval for Subcutaneous Tremfya Induction Regimen in Ulcerative Colitis
去年
Johnson & Johnson Seeks Approval for Daratumumab in High-Risk Smoldering Multiple Myeloma
去年
J&J Seeks Approval for Daratumumab in High-Risk Smoldering Multiple Myeloma
第 1 页,共 2408 页
上一页
下一页